LifeMD, Inc.
LifeMD, Inc. (LFMD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LFMD · as of Jun 8, 2026
Key Statistics
Explore LifeMD, Inc. Data
lfmd stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 100.0%
The LFMD analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $10.00, representing +101.41% upside from the current price of $4.96.
Competitors & Peers
lfmd competitorsLFMD
CERS
CVRX
HITI
MASS
OMIStock Performance
Full HistoryAbout LifeMD, Inc.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, …
what is lifemd, inc. · lfmd stock overview · lifemd, inc. company profile · who is lifemd, inc. ceo · lfmd NASDAQ · lifemd, inc. headquarters · lifemd, inc. business segments
About Stock Overview & Key Data
LifeMD, Inc. (LFMD) is a Healthcare company in the Medical - Pharmaceuticals industry, listed on NASDAQ since Jan 29, 2008. As of the latest trading session, LFMD stock price is $4.96, with a market capitalization of $239.2M. The stock has returned -60.28% over the past 12 months and +45.01% year-to-date.
According to 10 Wall Street analysts, the consensus rating for LifeMD, Inc. stock is Buy, with an average 12-month price target of $10.00. In fiscal year 2025, LifeMD, Inc. reported revenue of $194.1M and net income of -$7.1M. For detailed data — including LifeMD, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, LifeMD, Inc. (LFMD) stock price is $4.96. The stock is traded on NASDAQ under the ticker symbol LFMD. The 52-week range is $2.56 – $15.84.